Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

NCT04737070 - Study of High Risk Non Invasive Prenatal Test Population | Crick | Crick

Study of High Risk Non Invasive Prenatal Test Population

N/AUnknownNCT04737070

Central Hospital, Nancy, France150 enrolled

Overview

The investigator want to study the population of high risk (over 1/50) of Trisomy 21. According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Interventions

Prenatal test for Trisomy 21 screeningBIOLOGICAL

prenatal routine test for Trisomy 21 screening (blood test + nuchal translucency test)

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Prenatal screening of Trisomy 21 \> 1/50 (high risk population) Exclusion Criteria: * No exclusion criteria

Outcomes

Primary Outcomes

number of genetics anomalies

Time frame: through study completion, an average of 9 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.